EANS-Adhoc: Intercell announces next steps of development for Pseudomonas vaccine
Contact: Intercell AG Nina Waibel Corporate Communications Tel. +43 1 20620-1222 communications@intercell.com Branche: Biotechnology ISIN: AT0000612601 WKN: A0D8HW Index: ATX Prime, ATX Börsen: Wien / official market ...